Acquired von Willebrand syndrome: An update

American Journal of Hematology

Volumn 82, Issue 5, 2007, Pages 368-375

  Franchini, Massimo ^a,c   Lippi, Giuseppe ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c OSPEDALE POLICLINICO   (Italy)

Author keywords

Bleeding; Inhibitors; Von Willebrand syndrome

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; CIPROFLOXACIN; CORTICOSTEROID; DESMOPRESSIN; GRISEOFULVIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; VALPROIC ACID; VON WILLEBRAND FACTOR;

BLEEDING DISORDER; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG MEGADOSE; HUMAN; IMMUNOADSORPTION; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; MYELOPROLIFERATIVE DISORDER; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADAM PROTEINS; ADSORPTION; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLOOD COAGULATION TESTS; CARDIOVASCULAR DISEASES; DEAMINO ARGININE VASOPRESSIN; ENDOCRINE SYSTEM DISEASES; FACTOR VIII; HEMATOLOGIC DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 34247543029     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20830     Document Type: Review

References (146)

1. Shapiro S, Hultin M. Acquired inhibitors to coagulation factors. Semin Throm Haemost 1975;1:336-385.
2. Handin RI, Martin V, Moloney WC. Antibody induced von Willebrand syndrome. A newly defined inhibitor syndrome. Blood 1976;48:393-405.
3. Holland L, Adamson A, Ingram GIC, Chalmers DG. Acquired von Willebrand syndrome. Br J Haematol 1980; 45:161-164.
4. Bloom AL. The von Willebrand syndrome. Semin Hematol 1980;27:215-227.
5. Jakway J. Acquired von Willebrand's disease in malignancy. Semin Thromb Haemost 1992;18:434-439.
6. Cohen AJ, Kessler CM. Auto-antibody against inhibitors of von Willebrand factor protein. Baillieres Clin Haematol 1996;9:348-354.
7. Rinder MR, Richard RE, Rinder HM. Acquired von Willebrand disease: A concise review. Am J Haematol 1997;54:139-145.
8. Tefferi A, Nichols WL. Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis and treatment. Am J Med 1997;103:536-540.
9. Veyradier A, Jenkins CS, Fressinaud E, et al. Acquired von Willebrand syndrome: From pathophysiology to management. Thromb Haemost 2000;84:175-182.
10. Mohri H. Acquired von Willebrand syndrome: Its pathophysiology, laboratory features and management. J Thromb Thrombolysis 2003;15:141-149.
11. Federici AB, Budde U, Rand JH. Acquired von Willebrand syndrome 2004: International registry. Hamostaseologie 2004; 24:50-55.
12. Michiels JJ, Budde U, van der Planken M, van Vliet H, Schroyens W, Berneman Z. Acquired von Willebrand syndromes: Clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol 2001;14:401-436.
13. Lollar P. Pathogenic antibodies to coagulation factors, Part II: Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor. J Thromb Haemost 2005;3:1385-1391.
14. Simone JV, Cornet JA, Abildgaard CF. Acquired von Willebrand's syndrome in systemic lupus erythematous. Blood 1968;31:806-812.
15. Federici AB, Rand JH, Bucciarelli P, et al. Acquired von Willebrand syndrome: Data from an international registry. Thromb Haemost 2000;84:345-349.
16. Budde U, Bergemann F, Michiels JJ. Acquired von Willebrand syndrome: Experience from 2 years in a single laboratory compared with data from the literature and an international registry. Sem Thromb Hemost 2002;28:227-238.
17. Mannucci PM, Lombardi R, Bader R. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gamopathies. Blood 1984;64:614-621.
18. Mant MJ, Hirsch J, Gauldie J, Bienenstock J, Pineo J, Luke KH. von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy. Blood 1973;42:429-436.
19. Stewart AK, Glynn MF. Acquired von Willebrand disease associated with free λ light chain monoclonal gammopathy, normal bleeding time and response to prednisolone. Postgrad Med J 1990;66:560-562.
20. Federici AB, Stabile F, Castaman G, et al. Treatment of acquired von Willebrand disease in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches. Blood 1998;92:2707-2711.
21. Nitu-Whalley IC, Lee CA. Acquired von Willebrand syndrome - Report of 10 cases and review of the literature. Haemophilia 1999;5:318-326.
22. Federici AB, Rand JH, Mannucci PM. Acquired von Willebrand syndrome: An important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders. Hematol J 2001;2:358-362.
23. Maddox JM, Anderson JAM, Plews D, Ludlam CA. Management of acquired von Willebrand's syndrome in a patient requiring major surgery. Haemophilia 2005;11:633-637.
24. Sampson BM, Greaves M, Malia RG, Preston FE. Acquired von Willebrand's disease: Demonstration of circulating inhibitor to the FVIII complex in four cases. Br J Haematol 1983;54:233-244.
25. Bovill EG, Ershler WB, Golden EA, Tindle BH, Edson JR. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor. Am J Clin Pathol 1986;85:115-123.
26. Richard C, Cuardo MA, Prieto M. Acquired von Willebrand disease myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Haematol 1990;35:114-117.
27. Takahashi H, Nagayama R, Tanabe Y. DDAVP in acquired von Willebrand syndrome associated with multiple myeloma. Am J Haematol 1986;22:421-429.
28. Mohri H, Noguchi T, Kodama F, Itoh A, Ohkubo T. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor. Am J Clin Pathol 1987;87:663-668.
29. Mohri H, Tanabe J, Ohtsuka M, et al. Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor. Blood Coagul Fibrinolysis 1995;6:561-566.
30. Mazurier C, Parquet-Gernez A, Descamps J, Bauters F, Goudeman M. Acquired von Willebrand's syndrome in the course of Waldenstrom disease. Thromb Haemost 1980;44:115-118.
31. Brody JH, Haidar ME, Rossman RE. A haemorrhagic syndrome in Waldenstrom macroglobulinaemia secondary to immunoadsorption of factor VIII. N Engl J Med 1979;3000:408-410.
32. Wautier JL, Levy-Toledano S, Caen JP. Acquired von Willebrand's syndrome and thrombopathy in patient with chronic lymphocytic leukemia. Scand J Haematol 1976;16:128-134.
33. Roussi JH, Houbouyan LL, Alterescu L, Franc B, Goguel AF. Acquired von Willebrand's syndrome associated with hairy cell leukemia. Br J Haematol 1980;46:503.
34. Rao KP, Kizer J, Jones TJ, Anunciado A, Pepkowitz SH, Lazarchick J. Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma. Arch Pathol Lab Med 1988;112:47-50.
35. Tran-Thang C, Mannucci PM, Schneider P, Federici A, Bachmann F. Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma. Br J Haematol 1985;61:307-314.
36. Tefferi A, Hanson CA, Kurtin PJ, Katzmann JA, Dalton RJ, Nichols WL. Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein lb by marginal zone lymphoma cells. Br J Haematol 1997;96:850-853.
37. Kaywin P, McDonough M, Inact PA, Shattil SJ. Platelet function in essential thrombocythemia. N Engl J Med 1978; 299:505-509.
38. Raman BKS, Sawdyk M, Saced SM. Essential thrombocythemia with acquired von Willebrand's disease. Am J Clin Pathol 1987;88:102-106.
39. van Genderen PJ, Michiels JJ. Primary thrombocythemia: Diagnosis, clinical manifestations and management. Ann Hematol 1993;67:57-62.
40. Budde U, Scharf RE, Franke P, Hartmann-Budde K, Dent J, Ruggeri ZM. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 1993;82:1749-1757.
41. van Genderen PJ, Michiels JJ, van Spaceder Poel-van de Luytgaarde SC, van Vliet HH. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count. Ann Hematol 1994;69:81-84.
42. Castaman G, Lattuada A, Ruggeri M, Tosetto A, Mannucci PM, Rodeghiero F. Platelet von Willebrand factor abnormalities in myeloproliferative syndromes. Am J Hematol 1995; 49:289-293.
43. Budde U, van Genderen PJ. Acquired von Willebrand disease in patients with high platelet counts. Sem Thromb Haemost 1997;23:425-431.
44. van Genderen PJ, Leenknegt H, Michiels JJ. The paradox of bleeding and thrombosis in thrombocythemia: Is von Willebrand factor the link? Sem Thromb Haemost 1997;23:385-389.
45. van Genderen PJ, Prins FJ, Lucas IS, et al. Decreased half life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: Normalization after cytoreduction of the increased platelet count. Br J Haematol 1997;99: 832-836.
46. van Genderen PJ, van Vliet HH, Prins FJ, et al. Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma. Ann Haematol 1997;75:215-220.
47. Baud P, Tobler A, Lämmle B, Alberio L. Acquired von Willebrand syndrome in myeloproliferative disorder. Hämostaseologie 2003;23:121-124.
48. Mohri H. Acquired von Willebrand's disease in patients with polycythemia rubra vera. Am J Hematol 1987;26:135-146.
49. Duran-Saurez JR, Pico M, Zuazu J. Acquired von Willebrand's disease caused by a chronic granulocytic leukaemia. Br J Haematol 1981;48:173, 174.
50. Mohri H. Acquired von Willebrand's disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol 1986; 22:391-401.
51. Mohri H, Tanabe J, Yamazaki E, et al. Acquired type 2A von Willebrand disease in chronic myelocytic leukemia. Hematopathol Mol Hematol 1996;10:123-133.
52. Noronha PA, Houby MA, Maurer HS. Acquired von Willebrand disease in a patient with Wilm's tumor. J Pediatr 1979;95:997-999.
53. Scott JP, Montgomery RR, Tubergen DG, Hays T. Acquired von Willebrand's disease in association with Wilm's tumor: Regression after treatment. Blood 1987;58:247-257.
54. Bracey AW, Wu AHB, Aceves J. Platelet dysfunction associated with Wilms tumor and hyaluronic acid. Am J Hematol 1987;24:247-257.
55. Coppes MJ, Zandroort SWH, Sparling CR, Poon AO, Weitzman S, Blanchette VS. Acquired von Willebrand's disease in Wilm's tumor patient. J Clin Oncol 1992;10:422-427.
56. Jonge Paerink-Stockschlader AB, Dekker I, Risseeulus-Appel IM, Hählen K. Acquired von Willebrand's disease in children with Wilms tumor. Med Pediatr Oncol 1996;26:238-243.
57. Leung RS, Liesner R, Brock P. Coagulopathy as a presenting feature of Wilms tumour. Eur J Pediatr 2004;163:369-373.
58. Facon T, Caron C, Courtin P, et al. Acquired type II von Willebrand disease associated with adrenal cortical carcinoma. Brit J Haematol 1992;80:488-494.
59. Nowak-Göttl U, Kehrel B, Budde U, Hoffman C, Winkelman W, Jürgens H. Acquired von Willebrand's disease in malignant peripheral neuroectodermal tumor. Med Pediatr Oncol 1995; 25:117-118.
60. Soff GA, Green D. Autoantibody to von Willebrand factor in systemic lupus erythematosus. J Lab Clin Med 1992;121:424-430.
61. Niiya M, Niiya K, Takazawa Y, et al. Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus. Blood Coagul Fibrinolysis 2002;13:361-365.
62. Dalton RG, Savidge GF, Matthews KB, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987;1:1007-1009.
63. MacCallum PK, Rodgers M, Taberner DA. Hypothyroidism and von Willebrand's disease. Lancet 1987;1:1314.
64. Smith SR, Auger MJ. Hypothyroidism and von Willebrand's disease. Lancet 1987;1:1314.
65. Thorton JG, Parpia LA, Minford AMB. Hypothyroidism and von Willebrand's disease. Lancet 1987;1:1314-1315.
66. Palareti G, Biagi G, Legrani C, et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 1989; 62:1053-1056.
67. Blessing NE, Hambley H, McDonald GA. Acquired von Willebrand's disease and hypothyroidism: Report of a case presenting menorrhagia. Postgrad Med J 1990;66:474-476.
68. Coccia MR, Barnes HV. Hypothyroidism and acquired von Willebrand's disease. J Adolesc Health 1991;12:152-154.
69. Levesque H, Borg JY, Cailleux N, et al. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Eur J Med 1993;2:287-288.
70. Bruggers CS, McElligott K, Rallison ML. Acquired von Willebrand in twins with autoimmune hypothyroidism: Response to desmopressin and L-thyroxine therapy. J Pediatr 1994;125:911-913.
71. Tjan-Heijen VC, Harthoom-Lasthuizen KJ, Kurstjens RM, Koolen MI. A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease. Neth J Med 1994;44:91-94.
72. Attivissimo LA, Lichtman SM, Klein I. Acquired von Willebrand's sindrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid 1995;5:399-401.
73. Aylesworht CA, Smallridge RC, Rick ME, Alving BM. Acquired von Willebrand's disease: A rare manifestation of postpartum thyroiditis. Am J Hematol 1995;50:217-219.
74. Franchini M, Zugni C, Veneri D, et al. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 2004; 89:1341-1346.
75. Franchini M, Veneri D, Lippi G. Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels. Thromb Haemost 2005;93:392-393.
76. Leone G, Pola P, Guerrera G, Bizzi B. Acquired von Willebrand's syndrome during collagen disorder. Haematologica 1974;59:212-220.
77. Mannucci PM, Lombardi R, Lattuada A, Perticucci E, Valsecchi R, Remuzzi G. Supranormal von Willebrand factor multimers in scleroderma. Blood 1987;73:1586-1591.
78. Yoshida H, Arai K, Wakashin M. Development of acquired von Willebrand's disease after mixed connective tissue disease. Am J Med 1988;85:445-446.
79. Lazarchick J, Green C. Acquired von Willebrand disease following bone marrow transplantation. Ann Clin Lab Sci 1994; 24:211-215.
80. Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986;67:758-761.
81. Rauch R, Budde U, Girish M, Klinge J, Hofbeck M. Acquired von Willebrand disease in an infant resolution by interventional occlusion of patent ductus arteriosus. Thromb Res 2001;102:407-409.
82. Froom P, Margulis T, Grenadier E, Palant A, David M, Aghai E. von Willebrand factor and mitral valve prolapse. Thromb Haemost 1988;60:230-231.
83. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: Is acquired von Willebrand's disease the link? Lancet 1992;340:35-37.
84. O'Brien JR, Etherington MD. Heart valve stenosis and von Willebrand's factor multimers. Lancet 1992;340:616.
85. Anderson RP, Mc Grawth K, Street A. Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve remplacement. Lancet 1996;347:689-690.
86. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-349.
87. Yoshida K, Tobe S, Kawata M, Yamaguchi M. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. Ann Thorac Surg 2006;81:490-494.
88. Conrad ME, LaTour LF. Acquired von Willebrand's disease, IgE polyclonal gammopathy and griseofulvin therapy. Am J Hematol 1992;41:143.
89. Castaman G, Rodeghiero F. Acquired transitory von Willebrand syndrome with ciprofloxacin. Lancet 1994;343:492.
90. Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin. Am J Hematol 1995;49:83-86.
91. Kreuz W, Linde R, Funk M, et al. Induction of von Willebrand disease type I by valproic acid. Lancet 1990;335: 1350-1351.
92. Strauss RG, Stump DC, Henriksen RA. Hydroxyethyl starch accentuates von Willebrand's disease. Transfusion 1985;25: 235-237.
93. Sanfelippo MJ, Subernola PD, Geimer NF. Development of a von Willebrand-like syndrome after use of hydroxyl starch. Am J Clin Pathol 1987;88:653-655.
94. Dalrymphyle-Hay M, Aitchison R, Collins R, Sekhar M, Calvin B. Hydroxy-ethyl starch induced acquired von Willebrand's disease. Clin Lab Haematol 1992;14:209-211.
95. Rock G, Adamkiewicz T, Nblanchette V, Poon A, Sparling C. Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII. Br J Haematol 1996; 93:684-687.
96. Gralnick HR, McKeown LP, Williams SB, Strafer BC, Pierce L. Plasma and platelet von Willebrand factor defects in uremia. Am J Med 1988;85:806-810.
97. Rodeghiero F, Castaman G, Lombardi R, Mannucci PM. von Willebrand factor abnormalities in two patients with uraemia. Lancet 1988;1:1016-1017.
98. Castaman GC, Rodeghiero F, Lattuada A, La Greca CZ, Mannucci PM. Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients. Am J Hematol 1993;44:266-269.
99. Wautier JL, Caen JP, Rymer R. Angiodysplasia in acquired von Willebrand disease. Lancet 1976;2:973.
100. Rosborough TK, Swaim WR. Acquired von Willebrand's disease, platelet-release defect and angiodysplasia. Am J Med 1978;65:96-100.
101. Mc Grawth KM, Johnson CA, Stuart JJ. Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia. Am J Med 1979;67:693-696.
102. Cass AJ, Bliss BP, Bolton RP, Cooper BT. Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand's disease. Br J Surg 1980;67:639-641.
103. Woodlock TJ, Francis CW, Rowe JM, Brown MJ, Marder VJ. Prolonged remission after life-threatening gastrointestinal hemorrhage from coexistent angiodysplasia and acquired bleeding diathesis. Am J Hematol 1988;27:125-131.
104. Fressinaud E, Meyer D. International survey of patients with von Willebrand disease and angiodysplasia. Thromb Haemost 1993;70:546.
105. Inbal A, Bank I, Zivelin A, et al. Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor. Br J Haematol 1997;96:179-182.
106. Alhumood SA, Devine DV, Lawson L, Nantel SH, Carter CJ. Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: Demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor. Am J Hematol 1999;60:151-157.
107. Warkentin TE, Moore CJ, Anand SS, Lonn EM, Morgan DJ. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 2003;17:272-286.
108. Kinoshita S, Yoshioka K, Kasahara M, Takamiya O. Acquired von Willebrand disease after Epstein-Barr virus infection. J Pediatr 1991;119:595-598.
109. Richard C, Sedano MC, Cuadrado MA, Recio M, Hermosa V, Zubizarreta A. Acquired von Willebrand's syndrome associated with hydatid disease of the spleen. Disappearance after splenectomy. Thromb Haemost 1984;52:90-93.
110. Clough V, MacFarlane IA, O'Connor J, Woud JK. Acquired von Willebrand's syndrome and Ehlers-Danlos syndrome presenting with gastrointestinal bleeding. Scand J Haematol 1979;22:305-310.
111. Parker RI, McKeown LP, Grallin SI, Gralnick HR. Absence of the largest platelet von Willebrand multimers in a patient with lactoferrin deficiency and a bleeding tendency. Thromb Haemost 1992;67:320-324.
112. Benson PJ, Peterson LC, Hasegaura DK, Smith CM. Abnormality of von Willebrand factor in patients with hemoglobin E-β thalassemia. Am J Clin Pathol 1990;93:395-399.
113. Sokol L, Stueben ET, Jaikishen JP, Lamarche MB. Turner syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease. Am J Hematol 2002;70:257-259.
114. Stableforth P, Tamagnini GL, Dormandy KM. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation. Br J Haematol 1976;33:565-573.
115. Franchini M, De Gironcoli M, Lippi G, et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haemophilia 2002;8:142-144.
116. Kumar S, Pruthi RK, Nichols WL. Acquired von Willebrand disease. Mayo Clin Proc 2002;77:181-187.
117. van Genderen PJ, Vink T, Michiels JJ, et al. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood 1994;84:3378-3384.
118. Goudemand J, Samor B, Caron C, et al. Acquired type II von Willebrand's disease: Demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment. Br J Haematol 1988;68:227-233.
119. Fricke WA, Brinkhous KM, Garris JB, Roberts HR. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: An assay for von Willebrand factor binding by antibody. Blood 1985;66:562-569.
120. Mohri H, Motomura S, Kanamori H, et al. Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 1998;91:3623-3629.
121. Gan TE, Sawers RJ, Koutts J. Pathogenesis of antibody-induced acquired von Willebrand syndrome. Am J Hematol 1980;9:363-371.
122. Scrobohaci ML, Daniel MT, Levy Y, et al. Expression of Gplb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease. Br J Haematol 1993;84:471-475.
123. Pareti FI, Lattuada A, Bressi C, et al. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000;102:1290-1295.
124. Sadler JE. Aortic stenosis, von Willebrand factor and bleeding. N Engl J Med 2003;349:323-325.
125. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity of sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol 1995;104:264-271.
126. van Genderen PJ, Vink T, Michiels JJ, van't Veer MB, Sixma JJ, van Vliet HH. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood 1994;84:3378-3384.
127. Siaka C, Rugeri L, Caron C, Goudemand J. A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Haemophilia 2003;9:303-308.
128. McCarroll DR, Ruggeri ZM, Montgomery RR. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: Discrimination between type I and type II von Willebrand's disease. J Lab Clin Med 1984;103:704-711.
129. Genderen PJJ, Boertjes RC, Mourik JA. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome. Thromb Haemost 1998;80:495-498.
130. Friederich PW, Wever PC, Briet E, Doorenbos CJ, Levi M. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease. Am J Hematol 2001;66:292-294.
131. Smaradottir A, Bona R. A case of acquired von Willebrand syndrome successfully treated with recombinant factor Vila during thyroidectomy. Thromb Haemost 2005;93:1009.
132. Federici AB. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Hum Immunol 2005;66:422-430.
133. Hayashi T, Yagi H, Suzuki H, et al. Low-dosage intravenous immunoglobulin in the management of a patient with acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance. Pathophysiol Haemost Thromb 2002;32:33-39.
134. Michiels JJ, van Vliet HH. Willebrand disease in monoclonal gammopathies: Effectiveness of high-dose intravenous immunoglobulin. Clin Appl Thromb Hemost 1999;5:152-157.
135. van Genderen PJ, Michiels JJ, Bakker JJ, van't Veer MB. Effectiveness of high-dose γ globulin therapy in acquired von Willebrand's disease. Vox Sang 1994;67:14-17.
136. Castaman G, Tosetto A, Rodeghiero F. Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VII concentrate. Am J Hematol 1992;41:132-136.
137. Delannoy A, Saillez AC. High-dose intravenous gammaglobulin for acquired von Willebrand's disease. Br J Haematol 1988; 70:387.
138. Arkel YS, Lynch J, Kamiyama M. Treatment of acquired von Willebrand syndrome with intravenous immunoglobulin. Thromb Haemost 1994;72:643-644.
139. Hanley D, Arkel YS, Lynch J, Kamiyama M. Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol 1994; 46:141-146.
140. Delmer A, Horellou MH, Brechot JM, et al. Acquired von Willebrand disease: Correction of hemostatic defect by high-dose intravenous immunoglobulins. Am J Hematol 1992; 40:151-152.
141. Macik BG, Gabriel DA, White GC II, High K, Roberts H. The use of high-dose intravenous γ-globulin in acquired von Willebrand syndrome. Arch Pathol Lab Med 1988;112:143-146.
142. Lipkind HS, Kurtis JD, Powrie R, Carpenter MW. Acquired von Willebrand disease: Management of labor and delivery with intravenous dexamethasone, continuous factor concentrate, and immunoglobulin infusion. Am J Obstet Gynecol 2005;192:2067-2070.
143. Frank RD, Kunz D, Wirtz DC. Acquired von Willebrand disease - Hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion. Am J Hematol 2002;70:64-71.
144. Silberstein LE, Abrahm J, Shattil SJ. The efficacy of intensive plasma exchange in acquired von Willebrand's disease. Transfusion 1987;27:234-237.
145. Clough V, MacFarlane IA, O'Connor J, Wood JK. Acquired von Willebrand's syndrome and Ehlers-Danlos syndrome presenting with gastro-intestinal bleeding. Scand J Haematol 1979;22:305-310.
146. Joist JH, Cowan F, Zimmerman TS. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder. N Engl J Med 1978;298:988-991.